IL-22-eGFP Mouse

Principal Investigator: 

Gregory SonnenbergHenry R. Erle, M.D.-Roberts Family Professor of Medicine and Professor of Microbiology and Immunology in Medicine

Name: C57BL/6-Tg(Il22-EGFP)1Gson/J

Strain: 035005

Modification: Transgenic

Description: IL-22-eGFP transgenic mice express enhanced GFP (eGFP) under the control of the interleukin 22 (Il22) promoter. IL22 is produced by group 3 innate lymphoid cells (ILC3s) in the intestine and CD4+ T cells and is associated with chronic intestinal inflammation. EGFP expression reflects IL22 production by ILC3s.

Application: Mouse model useful in visualizing IL22 production by  ILC3s and its implication in inflammatory bowel disease. 

Availability: Available from JAX with license from WCM.

*Availability and licensing conditions are subject to change.

Publications

Intellectual Property

Cornell Reference

  • D-9527

Contact Information

Iris Bica

For additional information please contact

Iris Bica
Business Development and Licensing Associate
Phone: (646) 962-5966
Email: ib342@cornell.edu